86 results
Page 2 of 5
424B5
ul940de8 lzl5vrow
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.1
43wzuc jw
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
uuz9hea6 vt2wr
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
8-K
4zx71grdq4dmthnfys1x
28 Apr 23
Other Events
8:00am
8-K
t2yphcjn
30 Dec 22
Other Events
5:00pm
8-K
EX-10.1
vc7fpxrfalssie28k
15 Sep 22
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
5:01pm
8-K
EX-10.2
r6ou569 pymyzz
15 Sep 22
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
5:01pm
8-K
2v5uzie5r1j16lk 6bs
1 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
EX-1.1
an99c
3 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
6fasz5b lh4yeborizy
9 Jun 21
VBI Vaccines Announces Multiple Abstracts Accepted for Poster Presentations at About Hepatitis B
8:00am
8-K
EX-10.2
5jj65a 8k
21 May 21
VBI Vaccines Announces $12 Million Second Tranche of Debt Financing with K2 HealthVentures
8:00am
8-K
EX-99.1
3fm cbbwmf7u
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am